Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Oncolytics Biotech completes enrollment in phase II Reolysin trial in head and neck cancers

March 25, 2011

Nordion cleared to begin two phase III TheraSphere trials in cancer

March 25, 2011

Novel B-raf kinase inhibitors presented by Novartis

March 25, 2011

Phase III study results detailed for abiraterone acetate in metastatic CRPC

March 25, 2011

Results from phase I/II trial of MDV-3100 in CRPC reveal long-term efficacy

March 25, 2011

Karus Therapeutics presents new PI3K inhibitors

March 25, 2011

New protein kinase inhibitors patented by Cylene Pharmaceuticals

March 25, 2011

Ambrilia Biopharma enters into agreement with ZBx for PSP-94

March 24, 2011

Portsmouth Technologies patents novel hydroxamate histone deacetylase inhibitors

March 24, 2011

Eisai receives European approval for Halaven in advanced breast cancer

March 24, 2011

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...